Previous close | 61.04 |
Open | 61.20 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 60.11 - 61.20 |
52-week range | 50.73 - 87.26 |
Volume | |
Avg. volume | 8,386 |
Market cap | 337.793M |
Beta (5Y monthly) | 0.77 |
PE ratio (TTM) | 0.11 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
CHICAGO, April 16, 2024--ADM (NYSE: ADM) will release financial results for the first quarter of 2024 before the market opens on Tuesday, April 30, 2024. A slide presentation will also be available for download. The company will host a webcast at 8 a.m. Central Time to discuss the results and provide a company update.
QUINCY, Ill., April 11, 2024--ADM Animal Nutrition, a division of ADM (NYSE: ADM), is expanding the recall announced on March, 30, 2024, to include the following additional products due to elevated levels of magnesium, sodium, calcium and/or phosphorus: Pen Pals® Chicken Starter-Grower (Product Nos. 70009AAA46 and 70009AAA44); Pen Pals Egg Maker Complete (Product No. 70010AAAE4); MaxLean GF Concentrate (Product No. 12354AAA); ShowTec Sow Ration with Thermal Care (Product No. 12343AAA); ShowTec B
Solugen, a rapidly scaling climate technology company revolutionizing everyday chemicals, broke ground on its new state-of-the-art biomanufacturing facility today during a ceremony held in Marshall, Minn. The new facility is the result of a strategic partnership with ADM (NYSE: ADM), a global leader in sustainably sourced solutions from nature, and aims to meet the increasing demand for sustainable solutions while bolstering domestic biomanufacturing capabilities.